PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
33640631-2	2021	To develop new hMAO-B inhibitors with neuroprotection, a novel series of 3,4-dihydrocoumarins was designed as selective and reversible hMAO-B inhibitors to treat PD.	3,4-dihydrocoumarin	73-93	monoamine oxidase B	Homo sapiens	15-21	
33640631-2	2021	To develop new hMAO-B inhibitors with neuroprotection, a novel series of 3,4-dihydrocoumarins was designed as selective and reversible hMAO-B inhibitors to treat PD.	3,4-dihydrocoumarin	73-93	monoamine oxidase B	Homo sapiens	135-141